Comments
The Department of Science and Technology (DST) will work jointly with Dr Reddy’s Laboratories Ltd, University of Hyderabad (UoH) and Dr Reddy’s Institute of Life Sciences (DRILS) for discovery and development of anti-psoriatic drugs.
An agreement was signed by the four partners here on Tuesday.
According to a release issued here today, the DST and DRL sponsored project will work on 12-R-Lipoxygenase as target for the discovery and development of drugs for psoriasis. The project cost is estimated at Rs 190 lakh.
The psoriasis and other skin disorders market is currently about $6-7 billion and expected to be reach $13 billion in the next 10 years.
In the long term, it is proposed to establish a national R&D facility to work on inflammatory disorders.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.